Kristin Patrick Acquires Shares of NAGE
Kristin Patrick purchased 31,746 shares of NAGE on June 24, 2026.
Key Points
- Kristin Patrick bought 31,746 shares of NAGE on June 24, 2026, with the stock trading at $3.42 on Saturday.
- Several institutional investors adjusted their positions in NAGE, with BlackRock, Inc. reducing its stake by 204,090 shares.
- Analysts from HC Wainwright & Co. and Canaccord Genuity maintained 'buy' ratings on NAGE with price targets up to $13.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 24, 2026, Kristin Patrick acquired 31,746 shares of NAGE. The transaction was not planned under Rule 10b5-1, and the stock was trading around $3.42 on Saturday.
Other Institutional Activity in NAGE
In recent institutional activity, BlackRock, Inc. reduced its stake in NAGE by 204,090 shares, holding 3,871,619 shares valued at approximately $17.07 million. SteelPeak Wealth, LLC opened a new position with 3,373,000 shares, valued at about $14.87 million. Arrowstreet Capital, Limited Partnership increased its holdings by 761,685 shares, reaching 2,378,437 shares worth $10.49 million, marking a 47.1% increase. Vanguard Capital Management LLC also initiated a new position with 2,149,277 shares valued at $9.48 million. Meanwhile, Tieton Capital Management, LLC added 384,062 shares, totaling 2,029,155 shares worth $8.95 million, a 23.3% increase.
Niagen Bioscience, Inc. Stock Up 4.0%
Shares of NAGE traded near $3.42 on Saturday. The company's market dynamics are influenced by various institutional movements and insider transactions, which investors closely monitor for potential impacts on stock performance.
$NAGE stock price
Daily closing prices, year to date. Not investment advice.
Insider Buying and Selling at Niagen Bioscience, Inc.
On June 24, 2026, multiple insiders, including Jaksch Frank Jr, Ng Wang Yu Gary, Cohen Ann, Patrick Kristin, Rubin Steven, and Shahbazi Hamed, each purchased 31,746 shares of NAGE. These transactions were not executed under a Rule 10b5-1 plan.
Analysts Set New Price Targets
On May 11, 2026, HC Wainwright & Co. maintained its 'buy' rating on NAGE with a price target of $11. Canaccord Genuity also maintained a 'buy' rating with a $10 target on May 5, 2026. The consensus among analysts is a 'buy' recommendation, with a mean target price reflecting positive expectations.
Bottom Line
Kristin Patrick's acquisition of shares in NAGE, alongside various institutional adjustments, highlights ongoing interest in the company. The insider purchase and positive analyst ratings suggest potential optimism. Investors often track these insider and institutional moves for insights, though it's important to note that such filings reflect past actions and may not indicate current positions.
Get Niagen Bioscience, Inc. alerts
New 13F filings, insider trades, and analyst moves on $NAGE, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.